A pharmacological model for calcium overload-induced tachycardia in isolated rat left atria

European Journal of Pharmacology

Volumn 576, Issue 1-3, 2007, Pages 122-131

  Wolkowicz, Paul E ^a   Grenett, Hernan E ^a   Huang, Jian ^a   Wu, Hsien Chin ^b   Ku, David D ^b   Urthaler, Ferdinand ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

2 APB; Atrial fibrillation; Atrial tachycardia; If; Na Ca exchanger

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 2 AMINOETHOXYDIPHENYLBORANE; 4 (2 BENZYLBENZOYL) 2,5 DIMETHYL 1H PYRROLE 3 CARBOXYLIC ACID METHYL ESTER; CALCIUM; FORSKOLIN; ISOPRENALINE; SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM OVERLOAD; CONTROLLED STUDY; HEART CONTRACTION; HEART LEFT ATRIUM; HEART PERFUSION; INTOXICATION; ISOLATED HEART; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; TACHYCARDIA;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ANIMALS; BENZAZEPINES; BORON COMPOUNDS; CALCIUM; CALCIUM CHANNEL AGONISTS; CARDIOTONIC AGENTS; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; HEART ATRIA; MALE; OUABAIN; PYRIMIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; RYANODINE; TACHYCARDIA;

EID: 35349027847     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.08.004     Document Type: Article

References (48)

1. Ahlquist R.P. Present state of alpha- and beta-adrenergic drugs. The adrenergic receptor. Am. Heart J. 92 (1976) 661-664
2. Ai X., Curran J.W., Shannon T.R., Bers D.M., and Pogwizd S.M. Ca/calmodulin-dependent protein kinase modulates cardiac RyR2 phosphorylation and SR Ca leak in heart failure. Circ. Res. 97 (2005) 1314-1322
3. Baruscotti M., Bucchi A., and DiFrancesco D. Physiology and pharmacology of the cardiac pacemaker current. Pharmacol. Ther. 107 (2005) 59-79
4. Belardinelli L., Shryock J.C., and Fraser H. Inhibition of late sodium current as a potential cardioprotective principle: effect of the late sodium current inhibitor ranolazine. Heart 92 suppl IV (2006) iv6-iv10
5. Bers D.M. Ca influx and sarcoplasmic reticulum Ca release in cardiac muscle activation during postrest recovery. Am. J. Physiol. 248 (1985) H366-H381
6. Bers D.M. Cardiac excitation-contraction coupling. Nature 415 (2002) 198-205
7. 3-induced Ca release. FASEB J. 16 (2002) 1145-1150
8. Camello C., Lomax R., Petersen O.H., and Tepikin A.V. Calcium leak from intracellular stores - the enigma of calcium signaling. Cell Calcium 32 (2002) 355-361
9. f in human atrial appendage fibres. J. Physiol. 357 (1984) 125II
10. Carnes C.A., Chung M.K., Nakayama T., Nakayama H., Baliga R.S., Piao S., Kanderian A., Pavia S., Hamlin R.L., McCarthy P.M., Bauer J.A., and Van Wagoner D.R. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ. Res. 89 (2001) e32-e38
11. f in non-pacemaker cells: role and pharmacological implications. Pharmacol. Res. 53 (2006) 416-423
12. Doerr T., and Trautwein W. On the mechanism of the "specific bradycardic action" of the verapamil derivative UL-FS-49. Naunyn-Schmiedeberg's Arch. Pharmacol. 341 (1990) 331-340
13. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am. J. Physiol. 245 (1983) C1-C14
14. Franckowiak G., Bechem M., Schramm M., and Thomas G. The optical isomers of the 1,4-dihyropyridine BAY K 8644 show opposite effects on Ca channels. Eur. J. Pharmacol. 114 (1985) 223-226
15. Friedrichs G.S. Experimental models of atrial fibrillation/flutter. J. Pharmacol. Toxicol. Methods 43 (2000) 117-123
16. Hüser J., Blatter L.A., and Lipsius S.L. Intracellular calcium release contributes to automaticity in cat atrial pacemaker cells. J. Physiol. 524 (2000) 415-422
17. Illanes A., and Marshall J.M. The effects of ouabain on isolated atria from the ground squirrel; comparison with rat and rabbit atria. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol. 248 (1964) 15-26
18. Jaïs P., Haïssaguerre M., Shah D.C., Chouairi S., Gencel L., Hocini M., and Clémenty J. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 95 (1997) 572-576
19. Ju Y.K., and Allen D.G. Intracellular calcium and NCX current in isolated toad pacemaker cells. J. Physiol. 508 (1998) 153-166
20. Kamp T.J., and Hall J.W. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ. Res. 87 (2000) 1095-1102
21. 2+ sparks. Circ. Res. 87 (2000) 106-111
22. Laurenza A., Sutkowski E.M., and Seamon K.B. Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action?. Trends Pharmacol. Sci. 10 (1989) 442-447
23. Li X., Zima A.V., Sheikh F., Blatter L.A., and Chen J. Endothelin-1-induced arrhythmogenic Ca signaling is abolished in atrial myocytes of inositol-1,4,5,-trisphosphate (IP3)-receptor type 2-deficient mice. Circ. Res. 96 (2005) 1274-1281
24. Lipp P., Paine M., Tovey S.C., Burrell K.M., Berridge M.J., Li W., and Bootman M.D. Functional InsP3 receptors that may modulate excitation-contraction coupling in the heart. Curr. Biol. 10 (2000) 939-942
25. Ma H.T., Venkatachalam K., Parys J.B., and Gill D.L. Modification of store-operated channel coupling and inositol trisphosphate receptor function by 2-aminoethoxydiphenylborane in DT40 lymphocytes. J. Biol. Chem. 277 (2002) 6915-6922
26. 3-induced Ca release. J. Biochem. 122 (1997) 498-505
27. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosenblitt N., and Marks A.R. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel. Defective regulation in failing heart. Cell 101 (2000) 365-376
28. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 415 (2002) 219-226
29. Nattel S. Driver regions in atrial fibrillation associated with congestive heart failure: where are they, and what are they telling us?. J. Cardiovasc. Electrophysiol. 16 (2005) 1359-1361
30. Perez O., Gay P., Franqueza L., Carrón R., Valenzuela C., Delprón E., and Tamargo J. Electromechanical effects of zatebradine on isolated guinea-pig cardiac preparations. J. Cardiovasc. Pharmacol. 22 (1995) 46-54
31. Pogwizd S.M., and Bers D.M. Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc. Med. 14 (2004) 61-66
32. Qu J., Plotnikov A.N., Danilo P., Shlapakova I., Cohen I.S., Robinson R.B., and Rosen M.R. Expression and function of a biological pacemaker in canine heart. Circulation 107 (2003) 1106-1109
33. Rostock T., Rotter M., Sanders P., Jaïs P., Hocini M., Takahashi Y., Sacher F., Jönsson A., O'Neill M.D., Hsu L.F., Clémenty J., and Haïssaguerre M. Fibrillating areas isolated within the left atrium after radiofrequency linear catheter ablation. J. Cardiovasc. Electrophysiol. 17 (2006) 807-812
34. Sanders L., Rakovic S., Lowe M., Mattick P.A.D., and Terrar D.A. Fundamental importance of Na-Ca exchange for the pacemaking mechanisms of guinea-pig sino-atrial node. J. Physiol. 571 (2006) 639-649
35. i, SR Ca load, and rest on Ca spark frequency in ventricular myocytes. Am. J. Physiol. 272 (1997) H657-H668
36. Shah D., Haïssaguerre M., Jaïs P., Hocini M., Yamane T., Macle L., Choi K.J., and Clémenty J. Left atrial appendage activity masquerading as pulmonary vein potentials. Circulation 105 (2002) 2821-2825
37. Sutko J.L., Airey J.A., Welch W., and Ruet L. The pharmacology of ryanodine and related compounds. Pharmacol. Rev. 49 (1997) 53-98
38. 3 receptor can function as a Ca-leak channel: cell biological and pathological consequences. Biol. Cell 98 (2006) 1-14
39. Tai C.T., Chiou C.W., and Chen S.A. Interaction between the autonomic nervous system and atrial tachyarrhythmias. J. Cardiovasc. Electrophysiol. 13 (2004) 83-87
40. Tavi P., Pikkarainen S., Ronkainen J., Niemela P., Ilves M., Weckstrom M., Vuolteenaho O., Bruton J., Westerblad H., and Ruskoaho H. Pacing-induced calcineurin activation controls cardiac Ca signaling and gene expression. J. Physiol. 554 (2003) 309-320
41. Tieleman R.G., DeLangen C., Van Gelder I.C., de Kam P.J., Grandjean J., Bel K.J., Wijffels M.C., Allessie M.A., and Crijns H.J. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 95 (1997) 1945-1953
42. Vassalle M., and Lin C.I. Calcium overload and cardiac function. J. Biomed. Sci. 11 (2004) 542-565
43. 2-type 1 receptor increases rat atrial contractility via a Y-27632-sensitive pathway. Prostaglandins Other Lipid Mediat. 78 (2002) 91-105
44. Wolkowicz P.E., Grenett H.E., Belousova M., and Urthaler F. Activation of leptin expression by an inhibitor of carnitine palmitoyltransferase-1. Int. J. Obes. 28 (2004) 649-651
45. Wolkowicz P.E., Wu H.C., Urthaler F., and Ku D.D. 2-APB induces instability in rat left atrial mechanical activity. J. Cardiovasc. Pharmacol. 49 (2007) 325-335
46. Zheng W., Rampe D., and Triggle D.J. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel non-dihydropyridine Ca channel activator, in cardiac and vascular preparations. Mol. Pharmacol. 40 (1991) 734-741
47. Zima A.V., and Blatter L.A. Inositol 1,4,5-trisphosphate-dependent Ca signaling in cat atrial excitation-contraction coupling and arrhythmias. J. Physiol. 555 (2004) 607-615
48. f in left human atrium: a potential contributor to atrial ectopy. Cardiovasc. Res. 64 (2004) 250-259